November 11, 2015

Cologne eye researchers take the cake at DOG 2015

A staggering number of prizes were awarded to young Cologne ophthalmologists at the Sicca symposium held in Berlin during the annual meeting of the German Society of Ophthalmologists (DOG) on Friday, October 2nd, 2015. Five of the fourteen talks and three of the five projects that were selected for an […]
October 2, 2015

Visiting Professor Dr. Stern delights again

With clarity, warmth and humor, ocular immunologist Dr. Michael E. Stern mesmerized the audience with a lecture on “Aspects of aging and inflammation in dry eye disease” in his second visit to the University of Cologne. His talk was held on September 29th, 2015 in the CECAD lecture hall on […]
October 2, 2015

BEAT-ROP: Beat retinal angiogenesis in Retinopathy of Prematurity

Dr. Andreas Stahl (Freiburg i.Br.) was a Visiting Scientist at the Department of Ophthalmology at the University of Cologne on September 17th, 2015, invited by Univ.-Prof. Dr. med. Claus Cursiefen, Speaker of the DFG research unit FOR2240 “Angiogenesis, lymph angiogenesis and cellular immunity in inflammatory diseases of the eye” and […]
September 18, 2015

A visit from Michigan

The Department of Ophthalmology at the University of Cologne was the proud host of Dr. Lars Fritsche from the Center for Statistical Genetics at the University of Michigan, USA. On Thursday, August 27th, Prof. Langmann (right), the Vice-Speaker of the Research Unit FOR2240 and Endowed Professor of Experimental Immunology of […]
September 11, 2015

Three million Euros for better vision for longer

Three million Euros for better vision for longer: German Research Foundation approves funding for a new research unit at University Hospital Cologne Good vision is only possible when the anterior part of the eye is transparent. However, when inflammatory reactions in the eye occur, these lead to loss of transparency […]
September 11, 2015


July 14, 2015

Green light for sight

The 3rd Annual Scientific Retreat of the Center for Ophthalmological Treatment becomes the inaugural meeting of the new Research Unit FOR 2240 “(Lymph)angiogenesis and Cellular Immunity In Inflammatory Diseases of the Eye”